GLP-1 is derived from preproglucagon (PPG) and is widely known as an anorexigenic peptide and its analogue has already been approved as an anti-obesity drug by the FDA [8]. The gene discussed is GLP1R; the disease is obesity due to melanocortin 4 receptor deficiency.